glucose, (beta-d)-isomer has been researched along with Granulocytic Leukemia, Chronic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amar, M; Amit, N; Hakim, J; Pham Huu, T | 1 |
| Amar, M; Amit, N; Babin-Chevaye, C; Hakim, J; Huu, TP; Pasquier, C; Scoazec, JY | 1 |
| Guseva, SA | 1 |
| Chai, Y; Chen, F; Li, Z; Liu, W; Xi, Y; Yang, P; Zhou, Q | 1 |
| Guo, Q; Hui, H; Li, H; Li, Z; Liu, X; Lu, N; Xu, J; Yang, H; Zhang, X; Zhou, Y | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Molecular mechanisms involved in the inhibition of neutrophil locomotion by tumor cells.
Topics: Animals; Anti-Inflammatory Agents; Biological Factors; Chemotaxis, Leukocyte; Humans; Inflammation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritonitis; Phagocytosis; Respiratory Burst; Rosette Formation; Tumor Cells, Cultured; Zymosan | 1993 |
1 trial(s) available for glucose, (beta-d)-isomer and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
[Use of the stimulants of nonspecific resistance in the complex treatment of infectious complications in patients with chronic myeloid leukemia].
Topics: Adjuvants, Immunologic; gamma-Globulins; Humans; Immune Tolerance; Immunization, Passive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutrophils; Opportunistic Infections; Prodigiozan; Respiratory Tract Infections; Zymosan | 1991 |
3 other study(ies) available for glucose, (beta-d)-isomer and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
K562 cells produce an anti-inflammatory factor that inhibits neutrophil functions in vivo.
Topics: Animals; Anti-Inflammatory Agents; Caseins; Cell Adhesion; Cell Degranulation; Cytokines; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Neutrophils; Opsonin Proteins; Peritonitis; Tumor Cells, Cultured; Zymosan | 1992 |
Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking.
Topics: Drugs, Chinese Herbal; Glucosides; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Network Pharmacology | 2023 |
Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Flavanones; GATA1 Transcription Factor; Glucosides; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Binding; Scutellaria baicalensis | 2016 |